Albert Bourla
Chairman & CEO at Pfizer Inc. · b. 1961
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Pfizer Inc., 3 years.
Chief executive roles
Mixed · grade D
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 50% of the scoring weight is on file.
- Dividends 15%
- 61
- Revenue growth 20%
- 68
- Earnings growth 15%
- 31
dividend grew 3.2% a year
6.3% a year in revenue
-4.5% a year in earnings per share
50% of the scoring weight is on file. Figures cover December 2018 – December 2025.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Pfizer Inc. April 23, 202692.3%
-
Pfizer Inc. April 24, 202591.4%
-
Pfizer Inc. April 25, 202492.6%
-
Pfizer Inc. April 27, 202394.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 12, 2026 | Pfizer Inc. | Open-market purchase | +38,000 | $26.34 | $1,000,920 |
| Feb 25, 2026 | Pfizer Inc. | Option exercise | +491,626 | $33.82 | $16,626,791 |
| Feb 25, 2026 | Pfizer Inc. | Shares withheld for tax | −8,303 | $27.09 | $224,928 |
| Feb 25, 2026 | Pfizer Inc. | Shares withheld for tax | −467,241 | $26.92 | $12,578,128 |
| Feb 27, 2025 | Pfizer Inc. | Option exercise | +582,823 | $31.31 | $18,248,188 |
| Feb 27, 2025 | Pfizer Inc. | Shares withheld for tax | −18,300 | $26.10 | $477,630 |
| Feb 27, 2025 | Pfizer Inc. | Shares withheld for tax | −545,855 | $26.06 | $14,224,981 |
| Feb 22, 2025 | Pfizer Inc. | Option exercise | +238,399 | $30.17 | $7,192,498 |
| Feb 22, 2025 | Pfizer Inc. | Shares withheld for tax | −8,835 | $26.30 | $232,361 |
| Feb 22, 2025 | Pfizer Inc. | Shares withheld for tax | −212,680 | $26.08 | $5,546,694 |
| Feb 23, 2024 | Pfizer Inc. | Option exercise | +127,674 | $27.34 | $3,490,607 |
| Feb 23, 2024 | Pfizer Inc. | Shares withheld for tax | −8,831 | $27.76 | $245,149 |
| Feb 23, 2024 | Pfizer Inc. | Shares withheld for tax | −103,178 | $27.37 | $2,823,982 |
| Feb 25, 2023 | Pfizer Inc. | Shares withheld for tax | −43,419 | $41.75 | $1,812,743 |
| Feb 22, 2023 | Pfizer Inc. | Shares withheld for tax | −61,994 | $42.38 | $2,627,306 |
Questions about Albert Bourla
What boards is Albert Bourla on?
Albert Bourla sits on the board of Pfizer Inc.
What company is Albert Bourla the CEO of?
Albert Bourla has been Chairman & CEO of Pfizer Inc. since January 2019.
How long has Albert Bourla served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.